Return to search

Fisher Wallace Laboratories nabs $2.5m

Fisher Wallace Laboratories, a provider of prescription wearable technology for the treatment of neuropsychiatric disorders, has secured $2.5 million in funding.

Fisher Wallace Laboratories, a provider of prescription wearable technology for the treatment of neuropsychiatric disorders, has secured $2.5 million in funding. SHUFL Capital led the round.

Source: Press Release